Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Opus Genetics, Inc. (IRD)

Compare
0.9799
+0.0473
+(5.07%)
At close: April 3 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,992
10,992
19,049
39,850
589
Operating Expense
45,066
45,066
29,612
21,624
23,294
Operating Income
-34,074
-34,074
-10,563
18,226
-22,705
Net Non Operating Interest Income Expense
--
--
-1,328
-9
-2
Other Income Expense
-23,458
-23,458
1,917
-14
-33,986
Pretax Income
-57,532
-57,532
-9,974
18,203
-56,693
Tax Provision
--
--
12
315
--
Net Income Common Stockholders
-57,532
-57,532
-9,986
17,888
-56,693
Diluted NI Available to Com Stockholders
-57,532
-57,532
-9,986
17,888
-56,693
Basic EPS
-1.09
-2.15
-0.46
0.90
-3.82
Diluted EPS
-1.09
-2.15
-0.46
0.87
-3.82
Basic Average Shares
24,877.7500
26,715.5260
21,589.8210
19,931.0800
14,852.7450
Diluted Average Shares
24,877.7500
26,715.5260
21,589.8210
20,597.2120
14,852.7450
Total Operating Income as Reported
-62,074
-62,074
-10,563
18,226
-22,705
Total Expenses
45,066
45,066
29,612
21,624
23,294
Net Income from Continuing & Discontinued Operation
-57,532
-57,532
-9,986
17,888
-56,693
Normalized Income
-29,604
-29,604
-10,049.2000
17,888
-22,864
Interest Expense
--
--
--
9
2
Net Interest Income
--
--
-1,328
-9
-2
EBIT
-57,532
-57,532
-9,974
18,212
-56,691
EBITDA
-57,522
-57,522
-9,968
18,216
-56,687
Reconciled Depreciation
10
10
6
4
4
Net Income from Continuing Operation Net Minority Interest
-57,532
-57,532
-9,986
17,888
-56,693
Total Unusual Items Excluding Goodwill
-27,928
-27,928
80
--
-33,829
Total Unusual Items
-27,928
-27,928
80
--
-33,829
Normalized EBITDA
-29,594
-29,594
-10,048
18,216
-22,858
Tax Rate for Calcs
--
--
0.0002
0
--
Tax Effect of Unusual Items
--
--
16.8000
--
--
12/31/2021 - 11/10/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNTB Connect Biopharma Holdings Limited
0.5900
-6.44%
 
IOBT IO Biotech, Inc.
1.0050
-6.07%
 
GRCE Grace Therapeutics, Inc.
2.2000
-4.76%
 
LPCN Lipocine Inc.
3.1000
-2.21%
 
MURA Mural Oncology plc
1.2300
-6.82%
 
APLT Applied Therapeutics, Inc.
0.4101
-7.01%
 
EYEN Eyenovia, Inc.
1.1100
-5.93%
 
ATRA Atara Biotherapeutics, Inc.
5.92
-3.43%
 
MIST Milestone Pharmaceuticals Inc.
0.7500
-6.61%
 
CANF Can-Fite BioPharma Ltd.
1.5100
-0.66%